Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Maxigen Biotech Inc receives HSA approval for GingivAid Collagen Bone Graft


Monday, 30 Dec 2013 04:09am EST 

Maxigen Biotech Inc:Says it has received an approval from Health Sciences Authority of Singapore, for its GingivAid Collagen Bone Graft. 

Company Quote

29.3
0.2 +0.69%
22 May 2015